Riskpilot← Back to searchSign inGet full accessPro dosis Oy
OYActiveY-tunnus 2189241-5Telakanmäenkatu 3Other human health activities n.e.c. · NACE 8699Est. 20081 employeeswww.prodosis.fi
Revenue 2025
EUR 298K
+84% vs 2025
EBITDA margin
26.8%
+74% vs 2025
Equity ratio
-37.4%
Financial strength
Net profit 2025
EUR 64K
+40% vs 2025
| Revenue | EUR 298K | +84% |
| EBITDA | EUR 80K | +74% |
| Net profit | EUR 64K | +40% |
| Total assets | EUR 160K | -27% |
| Equity | EUR -60K | -1289% |
| Employees | 1 | — |
Legal name
Pro dosis Oy
Y-tunnus number
2189241-5
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
11. huhtikuuta 2008
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Lääkehoidon tuki- ja asiantuntijapalvelut sekä lääke- ja terveydenhoitoon liittyvien tuotteiden ja tarvikkeiden, kemikalio-, rohdos- ja ravintoainevalmisteiden sekä kosmetiikan vähittäis- ja tukkumyynti, tuonti, vienti ja valmistus, työvoiman sekä koneiden, laitteiden, kalusteiden, asuin- ja liikekiinteistöjen sekä huoneistojen vuokraus. Yhtiö voi myös omistaa ja hallita arvopapereita, kiinteää ja irtainta omaisuutta, ostaa ja myydä arvopapereita, ostaa ja myydä asunto- ja kiinteistöyhtiön osakkeita sekä asuin- ja liikekiinteistöjä. Yhtiön toimialaan kuuluu myös lääke- ja apteekkialaan liittyvä konsultointi, tuotekehitys, terveys- ja markkinointipalvelujen myynti sekä terveys- ja sairaanhoitopalvelujen tuottaminen.
Address
Telakanmäenkatu 3
Phone
+3580505675292
Email
paula.timonen@prodosis.fi
Website
www.prodosis.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|
| Revenue | 21 | 2 | 10 | 162 | 298 |
| Staff expenses | −4 | −0 | 0 | 0 | 0 |
| EBITDA | 12 | −2 | 5 | 46 | 80 |
| Depreciation & amort. | −0 | — | −0 | −0 | −0 |
| EBIT | 11 | −2 | 5 | 46 | 80 |
| Net financials | −0 | 0 | 0 | −0 | 0 |
| Profit before tax | 11 | −2 | 5 | 46 | 80 |
| Tax | −0 | −0 | −0 | 0 | 16 |
| Net profit | 11 | −2 | 5 | 46 | 64 |
| Item | 2021 | 2022 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|
| Total assets | 16 | 12 | 14 | 219 | 160 |
| Equity | −50 | −52 | −50 | −4 | −60 |
| Long-term debt | 30 | 30 | 30 | 30 | 30 |
| Short-term debt | 36 | 34 | 34 | 193 | 70 |
| Total debt | 66 | 64 | 64 | 223 | 100 |
EBITDA margin
26.8%
This company
15.8%
Market median
+70% vs market
20212025
Equity ratio
-37.4%
This company
38.2%
Market median
-198% vs market
20212025
Return on equity
6419400.0%
This company
18.4%
Market median
+34887943% vs market
20212025
Net profit margin
21.5%
This company
8.1%
Market median
+165% vs market
20212025
Asset turnover
1.86×
This company
1.12×
Market median
+66% vs market
20212025
Debt / equity
3.68×
This company
0.62×
Market median
-494% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-05-01 – 2025-12-31
- Annual report 2025Filed via PRH / YTJ · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-05-01 – 2024-04-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MM Deputy auditor | Deputy auditor | 2026 |
LE | Audit | 2026 |
PI Chief Executive Officer | Chief Executive Officer | 2008 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2016 | |
| Board of Directors | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pro dosis Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Minna Marianne Peräkorpi | Deputy auditor | 0 companies |
| Linn Edith Viola Storm | Audit | 0 companies |
| Paula Irmeli Timonen | Chief Executive Officer | 0 companies |
| Katja Maarit Anneli Ojanperä | Board of Directors | 0 companies |
| Olli Henrik Timonen | Board of Directors | 0 companies |